AstraZeneca plc (LSE: AZN) beats the adjusted core EPS consensus of approx. USD 5.05 per share in its H1-2026 results (27 July 2026)
Pending
✦ AI-generated prediction
Published on 20. July 2026
·
Predicted for 27. July 2026
·
Based on: Historical Cycle
AstraZeneca beat in Q1 2026 with core EPS of USD 2.58 vs. consensus USD 2.52 (+2.4%) and beat the revenue consensus at USD 15.29B (+13% YoY). Drivers: Oncology (Tagrisso, Imfinzi, Enhertu) and Rare Disease. H1 consensus is approx. USD 5.05; AZN has beaten EPS in each of the past six quarters. No Polymarket contract; calibrated from earnings-beat streak and pipeline strength.
Data basis for this prediction
- AstraZeneca Q1 2026: Core-EPS 2,58 USD vs. Konsens 2,52 USD, Umsatz 15,29 Mrd. USD +13 % YoY (businesswire.com, 29.4.2026)
- AstraZeneca H1 2026 Ergebnistermin: 27. Juli 2026 (AZN IR-Kalender)
- H1 2026 Konsens-Core-EPS ca. 5,05 USD (Yahoo Finance / TipRanks, Stand 20.7.2026)
- AstraZeneca Onkologie-Pipeline: 5 Blockbuster mit kombiniertem Wachstum >15 % YoY (Q1 2026)
Note: This is an AI-generated statistical forecast for entertainment and information purposes. It does not constitute investment advice or a recommendation to buy or sell any financial instrument.
Verdict: Pending
This prediction is still open. It will be evaluated automatically against real-world sources after its due date.
📈 Economy
✦ AI
The Nikkei 225 hit an intraday high of ~68,830 on July 15, 2026, before a chip-stock selloff pushed the index to ~64,140 (July 17). USD/JPY sits at ~162.5 — an extremely weak yen benefits Japanese exporters (Toyota, Sony, Keyence, FANUC). The BOJ holds rates at 1.00% on July 30–31, 2026 (separate open prediction), and even a hike to 1.25% by October (further open prediction) would only moderately dampen the yen tailwind. Reaching 70,000 requires ~+9% from the July 17 level — achievable absent major new shocks. No corresponding Polymarket market available.
📈 Economy
✦ AI
TXN reports Q2 2026 results on July 22 after market close. Consensus EPS is $1.92 (Zacks: $1.91), with company guidance of $1.77–$2.05. Estimates rose 22.3% over the past 90 days, signaling positive demand trends in the Analog semiconductor segment. Polymarket prices ~80.5% probability that TXN generates >$4.0B Analog revenue — a broad beat indicator. TXN has beaten EPS consensus in 14 of the last 16 quarters. Automotive and industrial demand are recovering cyclically.
📈 Economy
✦ AI
Visa reports Q3 FY2026 results on July 28 after market close. Consensus EPS is $3.22 (+8.1% YoY vs. $2.98); full-year FY2026 consensus is $13.10 (+14.2% YoY). Visa's structurally strong global payments position, robust consumer spending, and elevated cross-border transaction volumes (driven by travel) support results. The company has beaten EPS estimates in 15 of the last 18 quarters. Polymarket lists no specific Visa earnings market; no external market odds are available.